Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05234866

Paradoxical Lucidity in Severe End-Stage Dementia

Status
Recruiting
Phase
Study type
Observational
Enrollment
520 (estimated)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cognitive decline in dementia is considered irreversible, however episodes of paradoxical lucidity (PL) in severe dementia suggest other mechanisms may be in play. Beyond anecdotal reports of transient PL events occurring in patients predominantly in late-stage dementia and typically lasting anywhere from a few minutes to several hours, little is known about PL. The study team proposes to develop and conduct a mixed methods prospective study of PL during end stage advanced dementia, creating a definition and measurement scale for PL in advanced dementia, and identifying the potential electro cortical biomarkers of PL in advanced dementia. This study will be divided in two phases: Phase I and Phase II. During Phase I, the study team will collect sufficient and necessary data through an online survey and focus groups as well as assess the safety and feasibility of using symptom diaries (also known as daily trackers or journals) and real-time video EEG monitoring (vEEG). After preliminary review of the study procedures, the PI will decide whether to move onto the Phase II. The second phase will aim to expand the study population and refine study methods as well as create a definition and measurement scale for PL in advances dementia.

Conditions

Timeline

Start date
2022-06-02
Primary completion
2026-03-31
Completion
2026-05-31
First posted
2022-02-10
Last updated
2025-08-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05234866. Inclusion in this directory is not an endorsement.